Ondine Biomedical Inc Announces Notice of Results, Investor Presentation, and AGM

Vancouver, Canada / ACCESSWIRE / May 28, 2024 / Ondine Biomedical Inc. (AIM:OBI) will publish its audited results for the year ended 31 December 2023 and the Annual Report 2023 on 7 June 2024. Dr. Nicolas Loebel, President and Chief Technology Officer, will deliver a live presentation on the Full Year Results via Investor Meet Company on 10 June 2024, at 16:30 BST (08:30 Pacific time).

The presentation is accessible to all existing and potential shareholders. Questions can be submitted in advance via the Investor Meet Company dashboard until 9 June 2024, 09:00 BST (01:00 Pacific time), or during the live presentation.

Investors can sign up for free on Investor Meet Company to join the presentation. Those already following Ondine Biomedical Inc. on the platform will be invited automatically.

The Annual Report 2023 will provide a comprehensive overview of the fiscal year and will be available on the company’s website on 7 June 2024. The presentation slides and recording will be posted online by 11 June 2024.

The 2024 Annual General Meeting (AGM) will be held virtually on 28 June 2024 at 16:00 BST (08:00 Pacific time) and can be attended by registered shareholders and their proxyholders via the link provided in the Notice of Meeting.